LeMaitre Vascular Inc. (NASDAQ:LMAT) shares traded up 4.8% on Monday . The company traded as high as $18.34 and last traded at $18.33, with a volume of 154,409 shares trading hands. The stock had previously closed at $17.49.

A number of research analysts have weighed in on the company. Zacks Investment Research upgraded LeMaitre Vascular from a “hold” rating to a “strong-buy” rating and set a $20.00 price target for the company in a research note on Friday, July 29th. Brean Capital restated a “buy” rating on shares of LeMaitre Vascular in a research note on Tuesday, May 3rd. Roth Capital raised their price target on LeMaitre Vascular from $18.00 to $18.50 and gave the company a “buy” rating in a research note on Tuesday, May 3rd. Canaccord Genuity reiterated a “buy” rating and set a $18.00 target price (up from $6.00) on shares of LeMaitre Vascular in a research note on Tuesday, May 3rd. Finally, Barrington Research lifted their target price on LeMaitre Vascular from $18.50 to $20.00 and gave the stock an “outperform” rating in a research note on Thursday, July 28th. Seven investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $18.72.

The firm has a 50 day moving average of $16.22 and a 200-day moving average of $15.18. The stock has a market capitalization of $333.09 million and a price-to-earnings ratio of 36.22.

LeMaitre Vascular (NASDAQ:LMAT) last posted its quarterly earnings results on Wednesday, July 27th. The company reported $0.14 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.03. The firm had revenue of $22.40 million for the quarter, compared to analyst estimates of $21.59 million. The firm’s quarterly revenue was up 12.6% on a year-over-year basis. Equities analysts predict that LeMaitre Vascular Inc. will post $0.55 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 6th. Investors of record on Monday, August 22nd will be paid a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date is Thursday, August 18th.

In other news, CEO George W. Lemaitre sold 6,800 shares of the stock in a transaction that occurred on Wednesday, August 24th. The stock was sold at an average price of $17.49, for a total value of $118,932.00. Following the completion of the sale, the chief executive officer now directly owns 3,491,564 shares of the company’s stock, valued at $61,067,454.36. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Trent G. Kamke sold 2,510 shares of the stock in a transaction that occurred on Friday, June 3rd. The stock was sold at an average price of $15.00, for a total value of $37,650.00. Following the completion of the sale, the insider now directly owns 15,573 shares of the company’s stock, valued at $233,595. The disclosure for this sale can be found here.

LeMaitre Vascular, Inc is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. It operates in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.